HDFCG15ETF vs SBI Healthcare Opportunities Fund
Portfolio Overlap Analysis · HDFC vs SBI
15.9%
Low Overlap
3 common stocks · Rank #14398 of 28,292 pairs
Common Holdings (3)
| Stock | Wt% in HDFCG15ETF | Wt% in SBI Healthcare Opportunities | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. Pharmaceuticals & Biotechnology | 10.65% | 8.44% | 8.44% |
Divi's Laboratories Ltd. Pharmaceuticals & Biotechnology | 7.55% | 3.74% | 3.74% |
Apollo Hospitals Enterprise Ltd. Healthcare Services | 5.76% | 3.69% | 3.69% |
Unique to HDFCG15ETF
- Mahindra & Mahindra Ltd.13.91%
- Infosys Limited12.84%
- Tata Consultancy Services Ltd.12.35%
- Hindustan Unilever Ltd.9.52%
- Maruti Suzuki India Limited8.94%
- Titan Company Ltd.8.19%
- TVS Motor Company Ltd.4.17%
Unique to SBI Healthcare Opportunities
- Max Healthcare Institute Ltd.4.82%
- Acutaas Chemicals Ltd.4.77%
- Torrent Pharmaceuticals Ltd.4.25%
- Lupin Ltd.4.23%
- Aster DM Healthcare Ltd.3.85%
- Biocon Ltd.3.59%
- Laurus Labs Ltd.3.48%
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology12.2% (2)
Healthcare Services3.7% (1)
Analysis
AI-generated comparative analysis coming soon.
More comparisons for HDFCG15ETF
- vs Nippon India ETF Nifty 50 Shar43.3% · 5 stocks
- vs SBI Nifty Consumption ETF36.0% · 8 stocks
- vs SBI Nifty India Consumption In36.0% · 8 stocks
- vs HDFC Nifty India Consumption I36.0% · 8 stocks
- vs NIPPON INDIA ETF NIFTY INDIA C35.9% · 8 stocks
More comparisons for SBI Healthcare Opportunities
- vs HDFC Pharma and Healthcare54.8% · 16 stocks
- vs HEALETF53.4% · 12 stocks
- vs NIPPON INDIA PHARMA48.6% · 19 stocks
- vs ICICI Prudential Nifty Pharma 44.1% · 11 stocks
- vs NH44.1% · 11 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.